Binding sites for *251-atrial natriuretic peptide (ANP)' in rat olfactory bulb membranes have been studied using pharmacological and biochemical methods. Various unlabeled ANP-related peptides were tested for the ability to inhibit the binding of the radioligand in membrane binding assays. and were the most potent inhibitors tested, both exhibiting an IC, value of 0.40 nM. and ANP were 3 and 70 times less potent, respectively. ANP (lll-126) was unable to inhibit the binding of the radioligand at a concentration of 1 PM. Several peptides unrelated to ANP were unable to inhibit the binding of the radioligand to rat olfactory bulb membranes. Membranes labeled with 12sI-ANP were incubated with cross-linking agents and subjected to SDS-PAGE followed by autoradiography. A band possessing an apparent molecular mass of 116 kDa was identified. The labeling of this band was progressively decreased by increasing concentrations of unlabeled ANP(99-126) (IC, = 0.6 nM) and by several other ANP-related peptides at nanomolar concentrations. For comparison purposes, ANP binding sites in rat aorta membranes were labeled with 1251-ANP and cross-linked using identical techniques. Three bands possessing molecular masses of 120, 72, and 62 kDa were identified. These results indicate that the ANP binding site in rat olfactory bulb membranes displays pharmacological and biochemical properties similar to peripheral ANP receptors.
. The molecular form of ANP that is believed to interact with peripheral organs is ANP . This 28 amino acid peptide has been isolated and sequenced from rat plasma and is assumed to be derived from the COOHterminal region of atria1 ANP Schwartz et al., 1985) . This hypothesis is supported by recent studies indicating that cardiac atria1 cells secrete a 15 kDa form of ANP, likely ANP( l-126) which is cleaved by a plasma component to form ANP(99-126) (Bloch et al., 1985; Glembotski and Gibson, 1985) . The physiological importance of the COOH-terminal region of ANP was suggested by the demonstration that conversion of the large, atria1 form of ANP to smaller forms by enzymatic treatment results in increased bioactivity in isolated smooth muscle preparations (Currie et al., 1984) .
A new direction for ANP research was opened by the recent immunohistochemical localization of atria1 peptides in rat brain (Jacobowitz et al., 1985; Kawata et al., 1986; Saper et al., 1985; Skofitsch et al., 1986) . ANP immunoreactive neurons were distributed in several regions of the brain but were most prominent in the anteroventral region of the third ventricle (AV3V). The distribution of ANP immunoreactive material in the rat brain has also been quantitated by radioimmunoassay (Kawata et al., 1986; Zamir et al., 1986) . ANP immunoreactive material in the hypothalamus has been characterized using biochemical techniques coupled with radioimmunoassay (Glembotski et al., 1985; Tanaka et al., 1984; Zamir et al., 1986) . The physiological significance of the ANP immunoreactive material found in the brain remains to be elucidated; however, the distribution of ANP immunoreactive neurons is consistent with their potential involvement in the regulation of fluid balance. In support of this idea, 2 studies investigating the effects of ANP in the CNS have demonstrated that (1) ANP injected into the AV3V is capable of raising blood pressure and heart rate (Sills et al., 1986) and (2) ANP injected into the third ventricle is able to antagonize the dipsogenic effects of angiotensin II (Nakamura et al., 1985) .
As with other peptide hormones and neurotransmitters, ANP is thought to produce its physiological effects by interacting with specific cell surface receptors on appropriate target tissues. Using radioligand binding techniques, high-affinity membrane binding sites specific for ANP have been identified and characterized in renal (Carrier et al., 1985; Napier et al., 1984) vascular (Hirata et al., 1984; Napier et al., 1984; Schenk et al., 1985; Schiffrin et al., 1985) and adrenal tissues Misono et al., 1985; Schiffrin et al., 1985) . ANP binding sites have also been identified in these tissues by autoradiography (Lynch et al., 1986; Von Schroeder et al., 1985) . Evidence that these peripheral binding sites may, in fact, represent physiological receptors for ANP is derived from the close correlation between the bioactive and pharmacological potencies of various ANPrelated peptides (Napier et al., 1984; Schiffiin et al., 1985) . Recently, biochemical studies using either photoactive derivatives of ANP or chemical cross-linking agents have identified a 3766 Wildey and Glembotski Vol. 6, No. 12, Dec. 1986 I 2 3 4 TIME (h) PROTEIN ( pg 1 Figure 1 . Characterization of the binding of lZ51-ANP to rat olfactory bulb membranes. A, Time course: Membranes (15 pg protein) were incubated with 100 PM l*+ANP for varying lengths of time at 4°C in the absence (r) or presence (X5') of 1 PM unlabeled ANP(99-126). The amount of radioactivity bound was determined by vacuum filtration as described in Materials and Methods. The amount of specifically bound radioactivity (5) was determined by subtracting the nonspecific from the corresponding total radioactivity bound. B, Tissue concentration dependence: Increasing amounts of membrane protein were incubated with 100 PM lZ51-ANP in a constant volume of assay buffer (100 ~1) in the presence and absence of 1 PM unlabeled ANP(99-126) for 2 hr at 4°C. The amount of specifically bound radioactivity was determined as described above.
protein band displaying an apparent molecular mass of 120-140 kDa as the putative ANP binding site in bovine and rat adrenal cortical membranes (Hirose et al., 1985; Misono et al., 1985) and in rat kidney cortical membranes (Yip et al., 1985) . However, in rabbit aorta (Vandlen et al., 1985) and bovine adrenal cortical (Meloche et al., 1986) membranes, and in cultured bovine endothelial and smooth muscle cells (Schenk et al., 1985) , a protein band with an approximate molecular mass of 60-70 kDa was prominently labeled using both photoaffinity ligands and chemical cross-linking agents.
In the CNS, specific binding sites for ANP have been demonstrated in discrete regions of the rat, guinea pig, and monkey brain using autoradiography (Gibson et al., 1986; Quit-ion et al., 1984 Quit-ion et al., , 1986 . The highest levels of these binding sites were found to be distributed in brain regions thought to be involved in cardiovascular regulation (subfomical organ, area postrema), as well as in the olfactory bulb. Further characterization of ANP binding sites in the CNS is necessary to help determine whether these binding sites represent ANP receptors. In this paper we report the pharmacological and structural characterization of ANP binding sites in the CNS using rat olfactory bulb membrane preparations. Established homobifunctional cross-linking agents were used in this study to identify the putative ANP binding site.
Materials
and Methods
Synthetic peptides were obtained from Penninsula Labs [ANP analogs, thyrotropin-releasing hormone (TRH)], Bachem p-endorphin, n-alanine-D-leucine enkephalin (DADLE), cY-melanocyte stimulating hormone ((u-MSH)], or Sigma Chemical Co. (insulin, vasopressin, angiotensin II) . (3JZ51-iodotyrosyF*) rat ANP ('251-ANP) (1960 ( -2090 was purchased from Amersham. Cross-linking agents and 2-mercaptoethanol were obtained from Pierce Chemical Co. Electrophoresis chemicals were obtained from BDH Chemical, Ltd. Aprotinin, 1, lo-o-phenanthroline, and all other biochemicals were purchased from Sigma Chemical Co.
Membrane preparation
Olfactory bulbs were dissected from male Sprague-Dawley rats (lOO-200 gm) and chilled in ice-cold wash buffer (150 mM NaCl, 5 mM TrisHCl, pH 7.4). Tissue was then minced with a razor blade and homogenized in ice-cold buffer (50 mM Tris-HCl, pH 7.4, 0.3 M sucrose, 1% BSA) using a Potter-Elvehjem tissue grinder (1 ml extraction buffer/ pair olfactory bulbs). The homogenate was centrifuged at 1000 x g for 10 min, and the resulting supematant fluid was collected and centrifuged at 30,000 x g for 30 min to obtain crude membrane pellets. Membrane pellets were resuspended in ice-cold binding buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM MgCl,, 1% BSA) at 2-3 mg protein/ml, frozen in liquid nitrogen, and stored at -20°C.
Rat aortas were dissected free of accompanying fat and homogenized in ice-cold buffer using a mortar and pestle with sand added as an abrasive (1 rat aorta/ml of extraction buffer). Membranes were obtained as described above and stored at a concentration of 0.2 mg protein/ml.
Binding assay
Stock membranes were quickly thawed, diluted with ice-cold binding buffer to which aprotinin and 1 , 1 0-o-phenanthroline were added [final concentration, 0.3 trypsin inhibitory units (TIU)/ml and 100 &ml, respectively] and rehomogenized. Routinely, 50 pl of this diluted membrane preparation (approximately 20 pg rat olfactory bulb or 10 pg rat aorta membrane protein) was added to 50 pl of binding buffer containing *251-ANP and various concentrations of unlabeled peptides, as needed. The assay was terminated by diluting the reaction mixture with 4 ml of ice-cold wash buffer followed by immediate filtration through glass fiber filter disks (Schleicher and Schuell#30) under vacuum. Presoaking the filter disks in 0.1% polyethyleneimine (PEI) and having isotonic saline in the wash buffer were found to be important in obt&ing low filter blanks (Misono et al., 1985 : Naoier et al.. 1984 : Schiffiin et al.. 1985 . Filters were placed in test tubes and counted for 2 min in an LRB Minigamma counter at 70% efficiency. The concentration of lZ51-ANP used in competition experiments was approximately 100 PM (25,OOG30,000 cpm/assay tube). For these analyses, 10 concentrations of unlabeled ANP-related peptides were included, spanning 5 orders of magnitude. Other compounds unrelated to ANP were included at concentrations indicated in the text. Unlabeled peptides were added as 1 OO-fold concentrates to assay tubes after being freshly diluted in binding buffer from stock solutions. Nonspecific binding was defined in the presence of 1 PM and represented less than 25% of total binding using rat olfactory bulb and aorta membranes.
Peptide stability studies
Experiments were carried out to determine the stability of the peptide ligand under the assay conditions employed in this study. Binding assays of standard 1251-ANP: Stock lZ51-ANP was analyzed by RP-HPLC using a C,,column equilibrated with 0.1% TFA. A gradient of acetonitrile from 4 to 76% was developed over 60 min at a constant flow rate of 1 ml/min.
Fractions were collected at 1 min intervals and analyzed for radioactivity.
B, Chromatograph of V-ANP bound to pellet: Membranes (185 pg protein) were incubated with 100 PM lZ51-ANP for 2 hr at 4°C and collected by centrifugation at 30,000 x gfor 30 min. Radioligand was dissociated from the membranes by suspending the pellet in extraction buffer (1% TFA, 5% formic acid, 1 M HCl, 1 M NaCl). The sample was prepared for RP-HPLC using a Sep-Pak C,, cartridge, as described in Materials and Methods and analyzed as described above. C, Representative chromatograph of unbound Y-ANP present in the assay medium: A routine binding assay was terminated by centrifugation, and the resulting supernatant fluid was collected and analyzed by RP-HPLC, as described in B. The recovery of radioactivity averaged 90% for these analyses. This experiment was performed 3 additional times, yielding results similar to those shown.
were performed under the standard conditions described above except that the assay was terminated by adding 400 pl of ice-cold wash buffer to the test tubes, followed by centrifugation at 30,000 x g for 30 min to separate bound from free ligand. The resulting supematant fluid was added to 4 vol of ice-cold extraction buffer [lo/a trifluoroacetic acid (TFA), 5% formic acid, 1 M HCl, 1% NaCl] (Bennet et al., 198 l) , frozen and thawed, then applied to Sep-Pak C,, cartridges (Waters). Radiolabeled ANP was eluted from the cartridges with 3 ml of 0.1% TFA containing 80% acetonitrile, evaporated under reduced pressure, reconstituted in 0.1% TFA, and analyzed by reversed-phase high-pressure liquid chromatography (RP-HPLC). RP-HPLC was performed using a Beckman model 334 gradient HPLC system and a 4 x 250 mm C,, PBondapak column (Waters) with the trifluoroacetic TFA/acetonitrile buffer system described previously (Bennet et al., 1981) . Fractions of HPLC eluate were collected at 1 min intervals and counted in an LKB Minigamma counter. Greater than 90% of the radioactivity collected from the supematant fluid of the centrifuged binding assay mixtures was routinely recovered in the RP-HPLC fractions.
The stability of the bound ligand was examined in one experiment. This was performed essentially as described above except that (1) the binding assay was scaled up 1 O-fold (1 ml of total assay mixture) to obtain enough bound l*+ANP for study, and (2) the binding assay was diluted with 9 ml of ice-cold wash buffer prior to centrifugation, with the resulting pellet being resuspended in 2.0 ml of ice-cold extraction buffer.
Chemical cross-linking studies
The volume of the binding assay described above was scaled up to 1 ml for cross-linking studies. After 2 hr of incubation, a 100 ~1 sample of the 1 ml mixture was removed and the extent of binding was determined by vacuum filtration, as described above. The remainder of the mixture was diluted with 9 ml of ice-cold wash buffer and centrifuged at 30,000 x g for 30 min at 4°C to terminate the assay. The resulting membrane pellets were washed by resuspension in 10 ml of ice-cold cross-linking buffer (50 mM sodium phosphate, pH 7.4, 150 mM NaCl) and collected again by centrifugation.
The resulting membrane pellets were resuspended in 1 ml of ice-cold cross-linking buffer. Cross-linking agents were freshly prepared in dimethyl sulfoxide and routinely added in a volume not exceeding 5 ~1. The final concentrations of cross-linking agents were 0.5 mM for disuccinimidyl suberate (DSS) and ethylene glycolyl bis(succinimidy1 suberate) (EGS), and 1 mM for 1,5-difluoro-2,4-dinitrobenzene (DFDNB), unless indicated otherwise. Cross-linking was allowed to proceed for 15 min at 4°C. The cross-linking reaction was quenched by adding 100 ~1 of 1 .O M Tris-HCl, pH 7.4, followed by immediate centrifugation for 30 min at 30,000 x g. The resulting membrane pellets were dissolved in 100 ~1 of SDS-PAGE sample buffer (1% SDS, 10% glycerol, 1% 2-mercaptoethanol, 50 mM Tris-HCl, pH 6.8), boiled for 5 mitt, and stored at 4°C until analyzed. Essentially all of the radioactivity expected from the filtration analysis of the 100 ~1 sample was recovered in the gel sample.
Electrophoresis
Samples were centrifuged in a Beckman microfuge for 1 min to remove unsolubilized material and then analyzed by SDS-PAGE according to the dicontinuous method of Laemmli (Laemmli, 1970) using a 4.5% stacking gel and an 8.5% resolving gel. The ratio of acrylamide/bis was 38/l. The thickness of the gel was 1.4 mm. Equal amounts of rat olfactory bulb membrane protein were always applied to each lane of a gel, and ranged from 115 to 175 Mg. After electrophoresis the resolving gels were stained with Coomassie Brilliant blue (500 mg/dl dissolved in 25% 2-propanol, 7% glacial acetic acid), destained (5% 2-propanol, 7% glacial acetic acid) and dried onto Whatman filter paper. Less than 5% of the applied radioactivity remained in the stacking gel after analysis. Autoradiograms were generated by apposing dried resolving gels against Kodak XAR-5 film for 2-3 weeks at -70°C and enhanced using Cronex intensifying screens. The molecular mass of labeled proteins was determined from a graph of the mobility of protein standards as a function of their molecular mass. The protein standards used to determine molecular mass were egg albumin (45 kDa), bovine albumin (66 kDa), phosphorylase b (97.4 kDa), fl-galactosidase (116 kDa), and myosin (205 kDa).
Densitometric analysis of autoradiograms
Densitometric analyses of autoradiograms were performed by a method similar to that previously described (Gibson et al., 1986 -LOG CANPI, (Ml 
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grams were placed over a photocell that recorded the transmittance of light from an overhead source, from which the optical density (O.D.) was calculated. For each lane on the autoradiogram, 6-8 readings were taken of each specifically labeled band, from which the surrounding background intensity of the given lane was subtracted.
Protein determination
Protein was determined by the method of Lowry (Lowry et al., 1951) using BSA as a standard. Aliquots of membrane preparations were centrifuged at 30,000 x g for 30 min to obtain membrane pellets, which were dissolved in 1 N NaOH prior to the assay.
Results

Binding of lz51-ANP to rat olfactory bulb membranes
Initial experiments demonstrated that rZSI-ANP bound to olfactory bulb membranes such that equilibrium was attained after 2 hr at 4°C (Fig. 1A) . Under these conditions the amount of specifically bound 1251-ANP was linear with respect to tissue content (Fig. 1B) .
Even though the binding assay was performed at 4°C in the presence of protease inhibitors, studies were performed to determine whether there was degradation of either the bound or free 1*51-ANP during the 2 hr incubation. RP-HPLC elution profiles of standard rZ51-ANP were compared with those of ligand that had been exposed to tissue. One experiment examining the stability of 1251-ANP bound to rat olfactory bulb membranes demonstrated that essentially all of the radioactivity recovered from the membrane pellet (Fig. 2B ) coeluted with standard Y-ANP ( Fig. 2A) . When the stability of the unbound ligand was examined, it was observed that 95% of the radioactivity present Vol. 6, No. 12, Dec. 1986 in the binding assay medium after incubation with olfactory bulb membranes coeluted with standard rzsI-ANP (Fig. 2C ).
Since the RP-HPLC properties of the labeled ligand were unchanged after incubation with rat olfactory bulb membranes, it was concluded that there was no significant proteolysis of ANP during the binding incubations. Several ANP-related peptides were tested for the ability to compete with rz51-ANP for binding sites in olfactory bulb membranes. A composite graph of the inhibition curves generated by these experiments is shown in Figure 3 . ANP(99-126) was equipotent with ANP(92-126) in the ability to inhibit the binding of radiolabeled ANP. ANP( 103-126) was approximately one-third as potent as ANP(99-126), while ANP( 103-l 23) was 70 times less potent. All ofthe inhibition curves appeared monophasic except for that of ANP( 103-123), which was rather shallow. This could indicate that ANP( 103-123) is interacting with a lower-affinity binding component, which has been reported previously Gibson et al., 1986; Napier et al., 1984) . ANP( 11 l-l 26) was unable to inhibit rZ51-ANP bind- ing to olfactory bulb membranes at concentrations up to 1 PM. These studies suggested that the binding site for 1251-ANP on rat olfactory bulb membranes exhibits specificity in its interaction with COOH-terminal fragments of rat ANP(l-128). The specificity of these binding sites was further emphasized by the inability of various peptides unrelated to ANP to inhibit the binding of 12SI-ANP to olfactory bulb membranes. In this regard, TRH, DADLE, ACTH(l-39), (Y-MSH, insulin, glucagon, &-endorphin( 1-3 l), angiotensin II, and vasopressin were all ineffective at a concentration of 1 PM. Isoproterenol, phentolamine, atropine, (+)butaclamol (all at 1 MM), and carbachol (1 mM) were also without effect.
Cross-linking studies of lZSI-ANP to rat olfactory bulb membranes Established chemical cross-linking methods were used to identify the binding sites in rat olfactory bulb membranes which were labeled by lz51-ANP. The specificity of the membrane binding reaction was maintained in these experiments by scaling up the pharmacological assay 1 O-fold. The homobifunctional crosslinking agent DFDNB was chosen for these studies because it had been used previously to label ANP receptors on rabbit aorta membranes and was also found to be the most efficient chemical cross-linking agent ofseveral tested (Vandlen et al., 1985) . Initial cross-linking studies using rat olfactory bulb membranes demonstrated that radioactivity was covalently incorporated into a single band displaying a molecular mass of about 116 kDa when analyzed by SDS-PAGE (Fig. 4, lane 1) . This band was not present when 1 MM unlabeled ANP(99-126) was included in the binding mixture (Fig. 4, lane 2) and was not seen in the absence of cross-linking agent (Fig. 4, lane 3) . Although bands of apparently lower molecular mass are often visible, they are more diffuse and less consistent in their intensity than the 116 kDa band.
When the concentration of DFDNB was varied up to 10 mM, a general increase in labeling of the 116 kDa band was observed (Fig. 5A) . Concentrations of DFDNB from 0.1 to 1 .O mM produced no alteration in the Coomassie blue staining pattern of the protein bands as compared to controls receiving no crosslinking agent, indicating that excessive cross-linking of membrane proteins was not occurring under these conditions (Fig.  5B) . At concentrations of DFDNB higher than 1 mM, however, the protein band pattern became more diffuse. Therefore, all further experiments using this cross-linking agent were done at a concentration of 1 mM.
Two other homobifunctional cross-linking agents, DSS and EGS, were also used to label the 1251-ANP binding site of rat olfactory bulb membranes. A protein band displaying an apparent molecular mass of 116 kDa was again observed employing either cross-linking agent (Fig. 6) . The concentration of DSS and EGS used in this experiment, 0.5 mM, also produced no alteration in the Coomassie blue staining pattern of the protein bands (not shown).
The specificity of labeling of the 116 kDa band by 1251-ANP was tested by scaling up the pharmacological competition binding assays previously described. The presence of increasing concentrations of unlabeled ANP(99-126) in the binding assay prior to cross-linking resulted in a progressive decrease in the labeling of the 116 kDa band (Fig. 7A) . The concentration of unlabeled ANP(99-126) that decreased the intensity of labeling of the 116 kDa band by 50% was estimated to be 0.6 nM by densitometric analysis (Fig. 7B) . This value was similar to the IC,, value obtained previously in competition binding assays.
When various ANP-related peptides were all used at a constant concentration (1 nM), clear differences were observed in the abilities of the atria1 peptides to inhibit the labeling of the 116 kDa band (Fig. 8A) . Upon densitometric analysis, it was apparent that the inhibitory abilities of the ANP-related pep-tides paralleled their rank order of potency in competition binding assays [i.e., > ANP(103-126) > ANP(103-123) > ANP(l1 l-126)] (Fig. 8B) .
Cross-linking of lZ51-ANP to rat aorta membranes For comparison purposes the cross-linking of lZ51-ANP to rat aorta membranes was performed. As expected, a 116 kDa band was labeled when rat olfactory bulb membranes were used (Fig.  9, lane 1) . Three bands were evident, however, when rat aorta membranes were used (Fig. 9, lane 3) . The most intensely labeled band migrated with an apparent molecular mass of about 120 kDa, while 2 minor bands displaying molecular masses of about 72 and 62 kDa were also observed.
Discussion
In the present study, we have cross-linked lZ51-ANP to an olfactory bulb membrane protein displaying a molecular mass of 116 kDa upon SDS-PAGE. The specificity of labeling of this band was insured by scaling up the pharmacological binding assay that had been rigorously tested for its specificity using several ANP-related peptides, as well as many peptides unrelated to ANP. Furthermore, the intensity of labeling of this band could be reduced in a dose-dependent manner using increasing concentrations of unlabeled ANP(99-126), and in a potency-dependent manner using various peptides related to ANP. Collectively, these results strongly suggest that the ANP binding sites in rat olfactory bulb membranes measured in pharmacological binding assays are visualized as the 116 kDa band. This is the first identification of a specific ANP binding protein in the central nervous system.
Molecular mass of ANP binding sites
The concentrations of cross-linking agents used in this study were carefully determined such that there was no observable change in the Coomassie blue staining patterns of the membrane proteins compared to controls subjected to no cross-linking agents (Fig. 5) . This indicated that neighboring membrane proteins were not covalently coupled to the binding protein. Therefore, the band visualized on autoradiographs represents a close approximation of the actual molecular mass of the ANP binding site in the rat olfactory bulb. Since the ANP bound to membranes was shown by HPLC studies to be structurally intact, an estimated molecular mass for the ANP binding site of 113 kDa can be calculated by subtraction of the molecular mass of the crosslinked ANP (about 3 kDa) from 116 kDa. Since rat olfactory bulb membranes were reduced with 2-mercaptoethanol prior to SDS-PAGE, this 116-kDa band is likely a monomer. However, the possibility that other minor bands are present but not apparent due to the experimental conditions employed in this study cannot be excluded.
Previous studies have identified the putative ANP receptor in several peripheral tissues. Using either photoactive derivatives of ANP or chemical cross-linking agents, only a single band was labeled in bovine and rat adrenal cortical membranes (Hirose et al., 1985; Misono et al., 1985) and in rat kidney cortical membranes (Yip et al., 1985) . There is disagreement in these studies, however, over the effect of reducing agents on the apparent size of peripheral ANP receptors. In rat kidney cortex, the molecular mass of the ANP receptor was 140 kDa in the absence or presence of dithiothreitol (DTT) (Yip et al., 1985) . In bovine adrenal cortex, however, the apparent molecular mass of the ANP receptor was decreased from 130 to 70 kDa under reducing conditions (Hirose et al., 1985) . Another study identified 2 bands in bovine adrenal cortex, displaying molecular masses of 68 and 114 kDa, which were labeled by 1251-ANP in the absence or presence of 2-mercaptoethanol (Meloche et al., 1986) . In rabbit aorta membranes both photoactive derivatives of ANP and chemical cross-linking agents labeled 3 bands dis- playing molecular masses of 120, 70, and 60 kDa (Vandlen et al., 1985) . This is similar to results obtained in the present study using rat aorta membranes (Fig. 9) . The reason for the multiple labeled bands in aortic tissue is puzzling since another study demonstrated that when lZ51-ANP was chemically cross-linked to cultured bovine aortic endothelial and smooth muscle cells, a protein band displaying a molecular mass of 66 kDa was predominantly labeled in both cell types, with a minor band of approximately 180 kDa (Schenk et al., 1985) . Membranes were reduced with 2-mercaptoethanol prior to SDS-PAGE in each of the 2 studies utilizing vascular tissue. Membranes were cross-linked with 1 mM DPDNB, and equal amounts of protein were subjected to SDS-PAGE. The 116 kDa band is indicated by the arrow on the right. B, Inhibition curve: An inhibition curve was generated by densitometric analysis of the intensity of the labeling of the 116 kDa band in A. Vol. 6, No. 12, Dec. 1986 NH,-terminal region. Similar results were obtained recently in a study using membranes prepared from guinea pig cerebellum and thalamus/hypothalamus (Quit-ion et al., 1986) . These ANPrelated peptides are similar, however, in that they all possess a disulfide bridge between cysteine residues at positions 105 and 121. The inability of ANP( 111-126) to inhibit the binding of '251-ANP to rat olfactory bulb membranes demonstrated the structural significance of the disulfide bridge to the binding potency of ANP-related peptides.
In peripheral bioassay model systems in which ANP produces clear physiological effects, it appears that alterations in the COOH-terminal region and disulfide bridge of ANP-related peptides are deleterious to biological potency. The rank order of potency of ANP-related peptides to produce renal vasodilation and natriuresis/diuresis in the canine kidney was ANP(99-126) > ANP(103-126) = ANP(l03-125) >> ANP(103-123) (Wakitani et al., 1985) . Similar results were obtained in the rat kidney (Tang et al., 1984) . Structure-activity relationships have also been studied using the ability of ANP to inhibit norepinephrine-induced contraction of rabbit aorta. Truncation of ANP at the COOH-terminus yielded peptides that were much less potent than those truncated at the NH,-terminal region . In another study, ANP(l03-126) was shown to be a more potent inhibitor of precontracted rabbit aorta and chick rectum than ANP( 103-l 23) (Geller et al., 1984) . is also more potent than ANP(103-123) in its ability to decrease angiotensin II-stimulated aldosterone release by isolated adrenal cells (Campbell et al., 1985) . In addition, the absence of the disulfide bridge in ANP-related peptides results in either a dramatic decrease (Schiller et al., 1985) or abolition of biological activity in several of the bioassays described above. The ANP binding site present in the rat olfactory bulb displays ligand-binding properties similar to peripheral ANP receptors. This suggests that ANP binding sites in the CNS may, in fact, represent ANP receptors. Confirmation of this hypothesis awaits further studies on the physiological effects of ANP in the CNS.
Functional significance of ANP binding sites in the brain
Previous reports from this and other laboratories have demonstrated the existence of binding sites for ANP in many regions of the CNS of the rat, guinea pig, and monkey using autoradiography (Gibson et al., 1986; Quit-ion et al., 1984 Quit-ion et al., , 1986 . In these studies, the highest levels of ANP binding sites were localized to the olfactory bulb and the circumventricular organs. Unlike the circumventricular organs, however, the olfactory bulb is located behind the blood-brain barrier and must therefore interact with ANP that is derived from within the CNS. The recent demonstration of ANP in the rat olfactory bulb using immunohistochemistry and radioimmunoassay (Kawata et al., 1986) suggests that ANP may be functioning as a neurotransmitter or neuromodulator in this brain structure. Since ANP in the brain may be functioning in a completely different capacity than in the periphery, 2 different receptor systems may be required.
Structural differences between peptide receptors located in the CNS and in the periphery have been shown in recent studies of cholecystokinin (CCK) receptors. Pancreatic CCK receptors of mice exhibit an apparent molecular mass of 80 kDa and 120 kDa under reducing and nonreducing conditions, respectively (Sakamoto et al., 1983 (Sakamoto et al., , 1984 . Cerebral cortical CCK receptors, however, migrate with an apparent molecular mass of 55 kDa in the absence or presence of reducing agent (Sakamoto et al., 1984) . These differences in the structural characteristics of CCK receptors are thought to underlie the differences seen in the binding affinity of various CCK analogs for brain versus pancreatic CCK receptors (Sakamoto et al., 1984) .
Insulin receptors in the brain, however, exhibit ligand selec- tivity for various insulin-related peptides comparable to peripheral insulin receptors (Havrankova et al., 1979) . Insulin receptors in the CNS are also similar to insulin receptors in adipose tissue in that they are composed of 2 subunits. The molecular mass of brain insulin receptors, however, is lower than that of adipose tissue under reducing and nonreducing conditions (Ciaraldi et al., 1985; Heidenreich et al., 1983) . These structural differences are believed to be attributable in part to differences in the carbohydrate composition of adipose versus brain insulin receptors (Boyd and Raizada, 1983; Heidenreich et al., 1983) .
ANP binding sites in the olfactory bulb display selectivity towards various ANP-related peptides, which is similar to that observed with peripheral ANP receptors. It is difficult, however, to make precise comparisons between the proteins labeled with lZSI-ANP in brain versus peripheral tissues since there is little agreement concerning the biochemical characteristics of peripheral ANP binding sites. A single protein band was labeled by lZSI-ANP in rat olfactory bulb membranes displaying a molecular mass of 116 kDa. This is similar to results obtained using bovine and rat adrenal cortical (Misono et al., 1985) and rat renal cortical (Yip et al., 1985) membranes, in which a single 125 or 140 kDa band was observed, respectively. While multiple bands were labeled by rzSI-ANP in membranes prepared from bovine adrenal cortex (Meloche et al., 1986 ) and rabbit aorta (Vandlen et al., 1985) , one of the bands identified in these 2 tissues displayed a high molecular mass (114 and 120 kDa, respectively), which is comparable to the molecular mass reported for ANP binding sites in the rat olfactory bulb in the present report. It is possible, therefore, that ANP binding sites in the olfactory bulb are structurally similar to peripheral ANP receptors. In this case, small differences in the biochemical characteristics of ANP receptors in the brain versus peripheral organs could be due to tissue-specific glycosylation, similar to the findings described above for the insulin receptor. The glycoprotein nature of kidney ANP receptors has been suggested by the increased electrophoretic mobility of the putative renal ANP receptor after digestion with glycosidases (Yip et al., 1985) .
The differences observed in the biochemical characteristics of peripheral ANP receptors could be attributable to proteolysis and/or incomplete reduction of membranes by reducing agents. This was shown to be the explanation for the diverse results obtained describing the subunit composition of insulin receptors in liver and fat tissue (Massague et al., 1980) . Future studies comparing the biochemical characteristics of ANP receptors in both peripheral tissues and in the brain are needed to establish the structural identity of the ANP receptor and to determine whether different molecular subtypes of the ANP receptor exist.
